tiprankstipranks
Inmune Bio Inc (INMB)
NASDAQ:INMB

Inmune Bio (INMB) Stock Investors

284 Followers
Based on 747,525 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold INMB
On average, investors allocate 0.00% of their portfolios to INMB
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 747,525 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding INMB

1.7%
Last 7
Days
1.7%
Last 30
Days
Percentages indicate the change in the number of portfolios holding INMB, out of 747,525 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

INMB Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,193 investors who made their portfolios public
The table shows changes in INMB in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

INMB Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
ChargePoint Holdings
4.17%
-1.00%
-2.43%
833.60M
Consumer Cyclical
Marathon Digital Holdings
5.78%
-0.18%
+0.20%
6.75B
Financial
DraftKings
5.81%
-1.48%
-2.00%
32.41B
Consumer Cyclical
Riot Platforms
5.15%
-0.53%
+0.54%
3.47B
Financial
Merck & Company
3.90%
-0.58%
+3.35%
318.55B
Healthcare
Coherus Biosciences
2.58%
-1.95%
-5.37%
188.15M
Healthcare
Bristol-Myers Squibb
3.23%
-0.90%
+1.25%
86.44B
Healthcare
Plug Power
5.02%
-1.49%
-3.21%
1.87B
Industrials
Blink Charging Co
5.22%
-1.85%
-4.77%
315.31M
Industrials
Block
4.24%
-1.18%
-0.17%
42.02B
Technology
Based on the activity of 747,525 active portfolios
Open your Smart Portfolio

INMB Investor Analysis

INMB investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
14.5%
of INMB holders
are under 35
Average Segment Performance
Average P/E Ratio20.77
Beta7.15
Dividend Yield6.79%
INMB investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
39.8%
of INMB holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.59
Beta11.22
Dividend Yield6.44%
INMB investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
45.8%
of INMB holders
are over 55
Average Segment Performance
Average P/E Ratio19.41
Beta3.84
Dividend Yield7.80%
Overview of age group and performance of INMB stock investors
See who invests in INMB according to age group and performance.

FAQ

How many retail Investors hold INMB?
<0.1% of TipRanks' retail investors hold INMB in their portfolios.
    What is INMB Investor Sentiment?
    INMB’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of INMB in the last 7 days?
      ▼ 1.7% of TipRanks' retail investors changed their holding of INMB in the last 7 days.
        What percentage of retail investors changed their holding of INMB in the last 30 days?
        ▼ 1.7% of TipRanks' retail investors changed their holding of INMB in the last 30 days.
          What is the average age of retail investors who hold INMB?
          The average age of INMB Holders is over 55.
            What other stocks have INMB investors also bought?
            INMB Investors also bought CHPT, MARA, DKNG, RIOT, MRK, CHRS, BMY, PLUG, BLNK, SQ.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              BCRXBioCryst
              CYTKCytokinetics
              DHRDanaher
              EWEdwards Lifesciences
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis